Report Summarizes HIV/AIDS Study Findings from Faculty of Medicine (Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques).

A recent study published in the journal Vaccines examined the impact of recombinant VSV-HIV prime, DNA-boost vaccine candidates on immunogenicity and viremia in SHIV-infected rhesus macaques. The researchers found that while the vaccinated animals developed non-neutralizing antibody responses against both HIV and the Ebola virus glycoprotein, these responses did not provide observable protection against SHIV infection. The study highlights the challenges in developing an effective vaccine for HIV and the need for further research in this area. The research was funded by the Canadian Institute of Health Research and the Independent Research Fund Denmark. [Extracted from the article]